Suppr超能文献

老年血液透析人群的发病率、死亡率及生活质量:老年研究结果

Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.

作者信息

Seckinger Joerg, Dschietzig Wilfried, Leimenstoll Gerd, Rob Peter M, Kuhlmann Martin K, Pommer Wolfgang, Fraass Uwe, Ritz Eberhard, Schwenger Vedat

机构信息

Division of Nephrology, Department of Internal Medicine, Zug Cantonal Hospital, Landhausstrasse 11, 6340 Baar, Switzerland.

Division of Nephrology, Department of Internal Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 162, 69120 Heidelberg, Germany.

出版信息

Clin Kidney J. 2016 Dec;9(6):839-848. doi: 10.1093/ckj/sfw087. Epub 2016 Sep 26.

Abstract

BACKGROUND

The physical-functional and social-emotional health as well as survival of the elderly (≥75 years of age) haemodialysis patient is commonly thought to be poor. In a prospective, multicentre, non-interventional, observational study, the morbidity, mortality and quality of life (QoL) in this patient group were examined and compared with a younger cohort.

METHODS

In 92 German dialysis centres, 2507 prevalent patients 19-98 years of age on haemodialysis for a median of 19.2 months were included in a drug monitoring study of darbepoetin alfa. To examine outcome and QoL parameters, 24 months of follow-up data in the age cohorts <75 and ≥75 years were analysed. Treatment parameters, adverse and intercurrent events, hospitalizations, morbidity and mortality were assessed. QoL was evaluated by means of the 47-item Functional Assessment of Chronic Illness Therapy-Anaemia score (FACT-An, version 4).

RESULTS

The 2-year mortality rate was 34.7% for the older cohort and 15.8% for the younger cohort. The mortality rate for the haemodialysed elderly patients was 6.2% higher in absolute value compared with the age-matched background population. A powerful predictor of survival was the baseline FACT-An score and a close correlation with the 20-item anaemia subscale (AnS) was demonstrated. While the social QoL in the elderly patients was more stable than in the younger cohort (leading to equivalent values at the end of the study period), a pronounced deterioration of physical and functional status was observed. The median number of all-cause hospital days per patient-year was 12.3 for the elderly cohort and 8.9 for the younger patient population. The overall 24-month hospitalization rate was only marginally higher in the elderly cohort (34.0 versus 33.3%).

CONCLUSIONS

In this observational study, the mortality rate of elderly haemodialysis patients was not exceedingly high compared with the age-matched background population. Furthermore, the hospitalization rate was only slightly higher compared with the younger age group and the median yearly hospitalization time trended lower compared with registry data. The social well-being of elderly haemodialysis patients showed a less pronounced decline over time and was equal to the score of the younger cohort at the end of the study period. The physical and functional status in the elderly patients was lower and showed a sharper decline over time. The baseline FACT-An score correlated closely with the 24-month survival probability.

摘要

背景

通常认为老年(≥75岁)血液透析患者的身体功能和社会情感健康以及生存率较差。在一项前瞻性、多中心、非干预性观察研究中,对该患者群体的发病率、死亡率和生活质量(QoL)进行了检查,并与较年轻的队列进行了比较。

方法

在92个德国透析中心,2507名年龄在19 - 98岁、正在接受血液透析且中位时间为19.2个月的现患患者被纳入了一项关于阿法依泊汀的药物监测研究。为了检查结局和QoL参数,分析了年龄<75岁和≥75岁队列的24个月随访数据。评估了治疗参数、不良和并发事件、住院情况、发病率和死亡率。通过47项慢性病治疗贫血功能评估量表(FACT - An,第4版)对QoL进行评估。

结果

老年队列的2年死亡率为34.7%,年轻队列的为15.8%。与年龄匹配的背景人群相比,老年血液透析患者的死亡率绝对值高出6.2%。生存的一个有力预测因素是基线FACT - An评分,并且证明其与20项贫血子量表(AnS)密切相关。虽然老年患者的社会QoL比年轻队列更稳定(在研究期结束时达到相当的值),但观察到其身体和功能状态明显恶化。老年队列中每位患者每年全因住院天数的中位数为12.3天,年轻患者群体为8.9天。老年队列的总体24个月住院率仅略高(34.0%对33.3%)。

结论

在这项观察研究中:与年龄匹配的背景人群相比,老年血液透析患者的死亡率并非极高。此外,与较年轻年龄组相比,住院率仅略高,并且每年住院时间中位数与登记数据相比呈下降趋势。老年血液透析患者的社会幸福感随时间的下降不太明显,并且在研究期结束时与年轻队列的评分相当。老年患者的身体和功能状态较低,并且随时间下降更为明显。基线FACT - An评分与24个月生存概率密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3152/5162412/87292a7c9ae8/sfw08701.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验